Search - tctmd.com

Displaying 201 - 220 of 540

Sort: Relevancy | Date

News Daily News

Un Estudio Informa sobre la Embolización Cerebral Durante la Realización de TAVR

April 29, 2015

News Daily News

Study Provides Insight Into Cerebral Embolization During TAVR

April 29, 2015

News Daily News

TAVR 后瓣周渗漏封堵能改善功能，但可能无法改善生存率

April 28, 2015

News Daily News

Post-TAVR Plugging of Paravalvular Leaks Improves Function But Probably Not Survival

April 28, 2015

News Daily News

El Taponamiento Post-TAVR de Fugas Paravalvulares Mejora la Función aunque Quizá No la Supervivencia

April 28, 2015

News Daily News

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Caitlin E. Cox

April 17, 2015

News Daily News

Best Degree of Oversizing Varies by TAVR Device

Caitlin E. Cox

April 17, 2015

News Daily News

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Todd Neale

April 10, 2015

News Daily News

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

March 25, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Conference News ACC 2015

DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume

Yael L. Maxwell

March 16, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Industry News

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

March 15, 2015

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

News Industry News

Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance

March 15, 2015

Presentation ACC 2015

Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable, High-Risk and Intermediate-Risk AS Patients

Presenter: Susheel K. Kodali

March 15, 2015

News Daily News

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

L.A. McKeown

March 10, 2015

News Daily News

Early Discharge After Transfemoral TAVR Safe in Selected Patients

Yael L. Maxwell

February 09, 2015

News Daily News

Six Years of UK TAVI Registry Provide Insight Into Long-term Outcomes

L.A. McKeown

February 05, 2015

News Daily News

Un Análisis del PARTNER Analiza los Predictores e Impacto Clínico de la Implantación de Marcapasos

January 28, 2015

Advertisement

Un Estudio Informa sobre la Embolización Cerebral Durante la Realización de TAVR

Study Provides Insight Into Cerebral Embolization During TAVR

TAVR 后瓣周渗漏封堵能改善功能，但可能无法改善生存率

Post-TAVR Plugging of Paravalvular Leaks Improves Function But Probably Not Survival

El Taponamiento Post-TAVR de Fugas Paravalvulares Mejora la Función aunque Quizá No la Supervivencia

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Best Degree of Oversizing Varies by TAVR Device

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance

Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable, High-Risk and Intermediate-Risk AS Patients

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

Early Discharge After Transfemoral TAVR Safe in Selected Patients

Six Years of UK TAVI Registry Provide Insight Into Long-term Outcomes

Un Análisis del PARTNER Analiza los Predictores e Impacto Clínico de la Implantación de Marcapasos

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content